Seres Therapeutics, Inc. · NASDAQ:MCRB

DesRosier Thomas sold 103 Seres Therapeutics, Inc. shares (Form 4)

Traded Nov 15 to Nov 16, 2026 · Filed Nov 17, 2026

From Nov 15 to Nov 16, 2026, DesRosier Thomas (See Remarks) sold 103 Seres Therapeutics, Inc. shares at US$1.38 for US$142 under a trading plan, leaving 8,258 shares. Filed Nov 17, 2026 (Form 4).

Sold
103 shares
Price
US$1.38
Value
US$142
Holding after
8,258 shares
Trading plan
Yes (Made under a plan set in advance)
Role
See Remarks

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Nov 15, 2026Common StockOption exercise2448,361Direct
Nov 16, 2026Common StockSale103US$1.388,258Direct

Source

Download original · View original at SEC

Related